These medications fall under the category of specialty drugs, so they tend to be in the higher price range
HOWEVER, IN THE EVENT THAT CUSTOMER UTILIZES OR CAUSES OTHERS TO USE THESE PRODUCTS OUTSIDE OF THE ABOVE RESTRICTIONS, CUSTOMER IS ACCEPTING SUCH RISKS OF DOING SO ON ITSELF, ABSOLVING SELLER OF ANY RESPONSIBILITY FOR SUCH CUSTOMER ACTIONS, AND SPECIFICALLY AGREES TO INDEMNIFY AND HOLD SELLER HARMLESS FOR ANY CLAIMS MADE BY ANY THIRD PARTY BECAUSE OF SUCH CUSTOMER ACTION

Clinical trial data shows that burping rates vary by drug and dose: Ozempic injection (semaglutide): Burping reported in 3% of patients at the 0.5 mg dose and 1% of patients at the 1 mg dose Wegovy injection (semaglutide): Burping reported in 7% of adults at the 2.4 mg dose Mounjaro and Zepbound (tirzepatide): Burping reported in 25% of patients across doses (Source: Drugs.com) These numbers likely underestimate real-world prevalence, as sulfur burps are often underreported in clinical trials or described under broader terms like belching or eructation. Some patients avoid mentioning it to their doctors out of embarrassment, as well
Understanding Semaglutide and Liraglutide Semaglutide and Liraglutide are glucagon-like peptide-1 (GLP-1) receptor agonists commonly used to treat type 2 diabetes and assist with weight loss in individuals struggling with obesity or being overweight
A combined drug delivery system is a novel method that combines two or more therapeutically active agents, such as biologics and small molecules, into a single formulation
Glossary of Key Terms References Reynolds JC, Lai RW, et al